BOOK
Pain Management, An Issue of Critical Nursing Clinics, E-Book
Stephen D. Krau | Maria Overstreet
(2017)
Additional Information
Book Details
Abstract
Dr. Stephen Krau, Consulting Editor of Critical Care Nursing Clinics, is stepping into the Guest Editor role, with colleague Dr. Maria Overstreet, to address the topic of pain management in the critically ill. The review articles in this issue will provide an up-to-date look at the current strategies to improve patient outcomes in pain management for those patients in the ICU. Top authors will be writing on the following topics: Physiology of Pain; Classifications of Pain; Current Trends in Pain Assessment; Spiritual Aspects of Pain; Pharmacologic Interventions for Pain Management; Non-Alliopathic Interventions for the Management of Pain; Pain Associated with Chest Tube Removal; Discomfort Associated with Respiratory Issues; Pain Management in Obstetrics; Technological Interventions for Acute Pain Management; Pain Management Services and Policy; and Management of Chronic Cardiac Angina. Readers will come away with the current knowledge in this important field.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Pain Management\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITORS | iii | ||
| AUTHORS | iii | ||
| Contents | v | ||
| Preface: Pain Today | v | ||
| Physiology of Pain | v | ||
| The Role of Pain Classification Systems in Pain Management | v | ||
| Postoperative Visual Analog Pain Scores and Overall Anesthesia Patient Satisfaction | v | ||
| Pharmacologic Interventions for Pain Management | v | ||
| Pain and Complementary Therapies | vi | ||
| Dyspnea | vi | ||
| Pain Management in Obstetrics | vi | ||
| Management of Chronic Stable Angina | vi | ||
| The Use of Remifentanil as the Primary Agent for Analgesia in Parturients | vii | ||
| Using Complementary and Alternative Medicine to Treat Pain and Agitation in Dementia: A Review of Randomized Controlled Tri ... | vii | ||
| CRITICAL CARE NURSING\rCLINICS OF NORTH AMERICA\r | viii | ||
| FORTHCOMING ISSUES | viii | ||
| March 2018 | viii | ||
| June 2018 | viii | ||
| September 2018 | viii | ||
| RECENT ISSUES | viii | ||
| September 2017 | viii | ||
| June 2017 | viii | ||
| March 2017 | viii | ||
| Preface:\rPain Today | ix | ||
| Physiology of Pain | 397 | ||
| Key points | 397 | ||
| INTRODUCTION | 397 | ||
| SCOPE OF PROBLEM | 397 | ||
| NOCICEPTION | 398 | ||
| NEUROPATHIC PAIN | 401 | ||
| CHRONIC VERSUS ACUTE PHYSIOLOGIC CHANGES | 402 | ||
| PAIN AND AGING POPULATION | 402 | ||
| SUMMARY | 404 | ||
| REFERENCES | 405 | ||
| The Role of Pain Classification Systems in Pain Management | 407 | ||
| Key points | 407 | ||
| INTRODUCTION | 407 | ||
| RELEVANCE TO CLINICAL PRACTICE | 408 | ||
| CLASSIFICATION SYSTEMS | 408 | ||
| Anatomic | 408 | ||
| Etiologic | 408 | ||
| Intensity | 408 | ||
| Duration | 409 | ||
| Pathophysiological | 410 | ||
| Psychological and Spiritual Aspects of Pain Classification | 411 | ||
| Other | 412 | ||
| PAIN CLASSIFICATION IN CLINICAL PRACTICE | 412 | ||
| CASE STUDY | 412 | ||
| Subjective | 413 | ||
| Objective | 413 | ||
| Assessment | 414 | ||
| Plan | 414 | ||
| CLASSIFYING PAIN | 414 | ||
| Chronic Pain | 415 | ||
| SUMMARY | 416 | ||
| REFERENCES | 416 | ||
| Postoperative Visual Analog Pain Scores and Overall Anesthesia Patient Satisfaction | 419 | ||
| Key points | 419 | ||
| INTRODUCTION | 419 | ||
| REVIEW OF LITERATURE | 420 | ||
| METHODS | 422 | ||
| RESULTS | 423 | ||
| Patients | 423 | ||
| Descriptive Statistics | 423 | ||
| Relationships Among Presurvey Measures | 423 | ||
| Relationships among survey and presurvey measures | 424 | ||
| DISCUSSION | 425 | ||
| SUMMARY | 425 | ||
| REFERENCES | 426 | ||
| Pharmacologic Interventions for Pain Management | 427 | ||
| Key points | 427 | ||
| INTRODUCTION | 427 | ||
| PAIN MANAGEMENT GUIDELINES | 428 | ||
| Ethical Guidelines | 428 | ||
| Joint Commission on Accreditation and Healthcare Organizations Guidelines | 429 | ||
| Current standards | 431 | ||
| Medicare Guidelines | 431 | ||
| National Pain Management Guidelines | 432 | ||
| ASSESSMENT TOOLS | 434 | ||
| Patients Who Can Communicate | 434 | ||
| Patients Who Cannot Communicate | 435 | ||
| CASE REPORT ON PAIN ASSESSMENT GUIDELINES AND TOOLS | 435 | ||
| GENERAL CONSIDERATIONS WITH PHARMACOLOGIC INTERVENTIONS | 436 | ||
| Patient-Centered Partnership | 436 | ||
| Special Population Considerations | 436 | ||
| Prior experience with opioids | 436 | ||
| Morbid obesity | 436 | ||
| Geriatric patients | 437 | ||
| Side Effect Considerations | 437 | ||
| COMMON INTRAVENOUS SEDATIVE ANALGESICS | 437 | ||
| Mechanism of Action | 438 | ||
| Uses | 438 | ||
| Safety Issues | 438 | ||
| Focused Monitoring | 438 | ||
| Mechanism of Action | 439 | ||
| Uses | 439 | ||
| Safety Issues | 439 | ||
| Focused Monitoring | 439 | ||
| Mechanism of Action | 440 | ||
| Uses | 440 | ||
| Safety Issues | 440 | ||
| Focused Monitoring | 440 | ||
| CASE REPORT REGARDING OPIOID EDUCATION | 441 | ||
| COMMON ORAL OPIOIDS | 441 | ||
| COMMON NONOPIOID ANALGESICS | 441 | ||
| Sedative Medications | 441 | ||
| Case Report Regarding Benzodiazepine | 441 | ||
| Mechanism of Action | 442 | ||
| Uses | 442 | ||
| Safety Issues | 442 | ||
| Focused Monitoring | 442 | ||
| Mechanism of Action | 443 | ||
| Uses | 443 | ||
| Safety Issues | 443 | ||
| Focused Monitoring | 443 | ||
| SUMMARY | 444 | ||
| REFERENCES | 445 | ||
| Pain and Complementary Therapies | 449 | ||
| Key points | 449 | ||
| INTRODUCTION | 449 | ||
| Pain | 449 | ||
| Prevalence of Pain and Complementary and Alternative Therapy Usage | 450 | ||
| The Role of Nurses | 450 | ||
| COMPLEMENTARY THERAPIES AND PAIN MANAGEMENT | 451 | ||
| Legal Issues and the Nurse Practice Act | 452 | ||
| ESSENTIAL OILS AND AROMATHERAPY | 452 | ||
| MUSIC THERAPY | 453 | ||
| GUIDED IMAGERY | 454 | ||
| ACUPUNCTURE | 455 | ||
| ACUPRESSURE | 456 | ||
| RELAXATION BREATHING | 456 | ||
| SUMMARY | 457 | ||
| REFERENCES | 458 | ||
| Dyspnea | 461 | ||
| Key points | 461 | ||
| INTRODUCTION | 461 | ||
| DYSPNEA MECHANISMS | 461 | ||
| ANTECEDENT CONDITIONS AND MECHANISMS | 462 | ||
| PREVALENCE, INTENSITY, AND DISTRESS IN THE INTENSIVE CARE UNIT | 464 | ||
| ASSESSMENT | 464 | ||
| Behavioral Symptom Assessment | 465 | ||
| Proxy Symptom Assessment | 465 | ||
| WHAT ARE CURRENT STRATEGIES FOR MANAGING DYSPNEA DURING CRITICAL ILLNESS? | 466 | ||
| SUMMARY | 468 | ||
| REFERENCES | 468 | ||
| Pain Management in Obstetrics | 471 | ||
| Key points | 471 | ||
| INTRODUCTION: NATURE OF PAIN DURING LABOR | 471 | ||
| HISTORY OF PAIN MANAGEMENT IN OBSTETRICS | 472 | ||
| PHYSIOLOGIC CHANGES DURING PREGNANCY | 473 | ||
| TYPES OF PAIN MANAGEMENT | 473 | ||
| Injectables | 473 | ||
| Inhalable Analgesic | 473 | ||
| Neuraxial Anesthesia | 479 | ||
| Side effects | 479 | ||
| Complications of neuraxial anesthesia | 479 | ||
| Local Anesthetics (Alternate Regional Analgesic Techniques) | 482 | ||
| DISCUSSION | 482 | ||
| REFERENCES | 482 | ||
| Management of Chronic Stable Angina | 487 | ||
| Key points | 487 | ||
| STRATEGIES TO PREVENT DISEASE PROGRESSION | 488 | ||
| STRATEGIES TO CONTROL ANGINA SYMPTOMS | 489 | ||
| QUALITY OF LIFE | 490 | ||
| REFERENCES | 492 | ||
| The Use of Remifentanil as the Primary Agent for Analgesia in Parturients | 495 | ||
| Key points | 495 | ||
| PAIN ASSOCIATED WITH LABOR | 495 | ||
| THE IMPORTANCE OF EXPLORING REMIFENTANIL AS AN OPTION FOR TREATING LABOR PAIN | 496 | ||
| FOUNDATIONAL PRINCIPLES | 497 | ||
| Pain of Labor | 497 | ||
| Pharmacology of Remifentanil | 498 | ||
| CONDITIONS IN WHICH STANDARD NEURAXIAL ANESTHESIA IS A NONOPTION | 498 | ||
| Remifentanil in Clinical Practice | 500 | ||
| REMIFENTANIL COMPARED WITH OTHER PARENTERAL OPIOIDS | 503 | ||
| Remifentanil Compared with Neuraxial Anesthesia | 504 | ||
| Methods of Delivery: An Important Consideration | 507 | ||
| DOSING AND TIMING | 509 | ||
| PUTTING THIS ALL TOGETHER | 510 | ||
| THE IMPORTANCE OF SAFETY | 510 | ||
| ETHICAL CONSIDERATIONS | 510 | ||
| EVIDENCE-BASED RECOMMENDATION | 514 | ||
| ACKNOWLEDGMENTS | 515 | ||
| REFERENCES | 515 | ||
| Using Complementary and Alternative Medicine to Treat Pain and Agitation in Dementia | 519 | ||
| Key points | 520 | ||
| INTRODUCTION | 520 | ||
| SEARCH STRATEGY | 520 | ||
| RESULTS | 521 | ||
| DISCUSSION | 521 | ||
| LIMITATIONS AND STRENGTHS | 533 | ||
| CONCLUSION AND RECOMMENDATIONS | 533 | ||
| REFERENCES | 534 |